[
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "May rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Candidate molecular markers of cetuximab resistance",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Candidate molecular markers of cetuximab resistance",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Silencing of miR-100 expression sensitizes gc cells to chemotherapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Human epithelium derived GC cells",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Upregulated-regulation sensitized CCL-244 cells to X-ray irradiation",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues, 30 CRC specimens",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-103/107 sensitized SGC7901/ADR cells to dexorubicin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "sample_type": "Cell-line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-106a suppressed sensitivity of Gc cells to anticancer drug(ADR,CDDP,5-FU)",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-106a in SGC7901 confers resistance to DDP",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in non-responders",
    "expression": "Upregulated",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "continent": "Europe",
    "population": "Norway",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Induced resistance to IR in vitro and in vivo in SW620 cells",
    "expression": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "Cell line HT29, SW480, SW620 and LOVO",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-103/107 sensitized SGC7901/ADR cells to dexorubicin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "sample_type": "Cell-line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predicts chemotherapy response",
    "expression": "Upregulated",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-10b confers chemoresistance in colorectal cancer cells to 5-FU",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "88 colorectal cancer cases",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Elevated expression confers radiosensitivity in EC cells",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Increased in bevacizumab-induced cardiotoxicity",
    "expression": "N/A",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Increased miR-125b level associated with trastuzumab resistance in HER2-positive gastric cancer (P<0.05).",
    "expression": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "132 GC & 38 non cancerous gastric tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Higher levels of miR-125b were associated with worse response to the therapy.",
    "expression": "Upregulated",
    "significance": "Fold Change=2.5, p=0.05",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "sample_type": "Tissue",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Marker for  response to first line XELOX in patients with mCRC",
    "expression": "Upregulated",
    "significance": "p<0.0001, PPV=90%, and NPV=71%",
    "detection_method": "In situ hybridization (ISH)",
    "sample_type": "Tissue",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "continent": "Europe",
    "population": "Denmark",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Related to the response to chemotherapy and bevacizumab",
    "expression": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "continent": "Europe",
    "population": "Denmark",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-127-3p increases chemosensitivity of EC patients to phenanthroline-dione derivative",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression decreases cisplatin resistance in cisplatin resistant GC cells",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cells",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in non-responders",
    "expression": "Upregulated",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "continent": "Europe",
    "population": "Norway",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Combined downregulation predicts paclitaxel based chemosensitivity of ESCC patients",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Combined downregulation predicts paclitaxel based chemosensitivity of ESCC patients",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Increase and decrease of miR-135a-5p inhibited or impaired adriamycin induced apoptosis in BGC-823 cells(p<0.05),compared with group without gene intervention",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "sample_type": "Tissue",
    "sample": "20 pairs GC & para cancerous tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Higher levels of miR-137 were associated with worse response to the therapy.",
    "expression": "Upregulated",
    "significance": "Fold Change=6.5, p = 0.0004",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "sample_type": "Tissue",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Knockdown miR-141 expression in 7901/DDP and 7901 cells could significantly improve cisplatin sensitivity",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "H.pylori infected GC tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Decitabine increased miR-200c and miR-141 expression",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "GC specimens, SGC-7901",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Confers resistance to cisplatin in cisplatin sensitive cell lines,order of decreasing sensitivity to Cisplatin:KYSE890>KYSE960>KYSE70>KYSE140>KYSE590>KYSE170>KYSE190>KYSE520>KYSE450",
    "expression": "Upregulated",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated regulation causes selective resistance to L-OHP and EMT",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-141-3p contributed to an acquired chemo resistance through PTEN modulation in vitro and in vivo",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpressed miR-143 sensitized SGC7901/DDP cells to cisplatin(DDP)",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,SGC7901,SGC7901/DDP",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Indicate successful neoadjuvant chemoradiotherapy",
    "expression": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "continent": "Europe",
    "population": "Germany",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Patients with a low intratumoral post-therapeutic expression of miR-145 had worse response to neoadjuvant therapy compared to patients with a high expression",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "continent": "Europe",
    "population": "Germany",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-148-3p sensitizes GC cells to CDDP",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "TCGA Dataset,GEO Dataset,Tissue,Cell-line",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "continent": "N/A",
    "population": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "In stage III and IV CRC, low miR-148a expression was associated with a worse therapeutic response",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "continent": "USA",
    "population": "USA",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients treated with fluoropyrimidines and high levels of miR-149 had longer overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients whose tumours had low miR-150 expression had worse response to adjuvant chemotherapy",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and In-situ Hybridization",
    "sample_type": "Tissue",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Re-elevated in patients not sensitized to chemotherapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-15b and  sensitize SGC7901/VCR cells to VCR induced apoptosis",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901/VCR,SGC7901",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-16 sensitize SGC7901/VCR cells to VCR induced apoptosis",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901/VCR,SGC7901",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Candidate molecular markers of cetuximab resistance",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Induces drug resistance, miR-17-5p was negatively related with chemosensitive status in CRC patients",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "Microarray and qRT-PCR",
    "sample_type": "Tissue",
    "sample": "295 patients, who underwent tumor resection",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients with high expression of miR-17-5p showed a better response to adjuvant chemotherapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "FFPE specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-181b expression reduced BCL2 protein level and sensitized SGC7901/VCR to VCR induced and CDDP induced apoptosis",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/VCR",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-185 enhances the sensitivity of GC cells to chemotherapy(cisplatin or doxorubicin)",
    "expression": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "25 patients GC & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Reduced expression during chemoradiotherapy was found to be significantly associated with postoperative lymph node negativity",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "sample_type": "Plasma",
    "sample": "Plasma of rectal cancer patients (n = 42)",
    "continent": "Europe",
    "population": "Germany",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "miR-193a-3p regulate chemoradiation resistance in EC cells via PSEN1 gene, overexpression of miR-193a-3p increases radioresistance and chemoresistance of ESCC cells",
    "expression": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "KYSE150,KYSE410",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "OE21,OE33(5FU chemosensitive),KYSE450,OE19(comparatively chemoresistant to 5FU)",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "For discriminating chemoresistant colon cancer",
    "expression": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-115",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression enhances 5FU sensitivity in SGC7901/5FU cells",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/5FU",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy.",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predicts resistance to FOLFOX chemotherapy in advanced colorectal cancercases",
    "expression": "Upregulated",
    "significance": "p=0.009, Sensitivity=66.7%, specificity=63.9% and AUC=0.679.",
    "detection_method": "Microarray",
    "sample_type": "Serum",
    "sample": "Serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients treated with fluoropyrimidines and high levels of miR-200a and miR-200c had longer overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Decitabine increased miR-200c and miR-141 expression",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "GC specimens, SGC-7901",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-200c expression correlated with response to chemotherapy(p=0.009 for clinical response &p=0.007 for pathological response)",
    "expression": "Upregulated",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Chemotherapy surgical tissues",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated regulation causes selective resistance to L-OHP and EMT",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients treated with fluoropyrimidines and high levels of miR-200a and miR-200c had longer overall survival",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy.",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "GEO Dataset",
    "sample": "Nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "continent": "N/A",
    "population": "NCBI GEO",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Increases sensitivity to oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "SP1 mediated transcriptional activation of miR-205 promotes radioresistance through PTEN",
    "expression": "Upregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Cisplatin docetaxel treatment suppressesgc cell movement via regulating miR-29c-mediated catenin-δ axis",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-20a promoted chemoresistance(cisplatin,docetaxel) of GC cells",
    "expression": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "28 GC & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in cisplatin resistant cell line",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "Plasma ,tissues,SGC7901/DDp,SGC7901",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Reduced expression during chemoradiotherapy was found to be significantly associated with postoperative lymph node negativity",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "Plasma samples, n=42",
    "continent": "Europe",
    "population": "Germany",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "sample_type": "Tissue Stool",
    "sample": "Tissue and Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Expression had no significance with CRT",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Serum",
    "sample": "21 ESCC & 21 healthy serum",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Associated with chemotherapeutic response",
    "expression": "Upregulated",
    "significance": "Sensitivity=80% and Specificity=88.2% for response to therapy",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Circulating miR-21 is an independent predictive biomarker for chemoresistance in ESCC",
    "expression": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma Tissue",
    "sample": "Plasma and surgical resesction",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-200c  associated with poor response to chemotherapy(p=0.0211)",
    "expression": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Serum miR-21 act as response marker for chemotherapy",
    "expression": "Upregulated",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Associated with poor response to adjuvant chemotherapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Paired tumor and normal mucosa samples",
    "continent": "Asia",
    "population": "Taiwan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Elevated expression of miR-21 reduced the sensitivity of RT",
    "expression": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "sample_type": "Tissue Serum",
    "sample": "Serum ,tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "therapy": "Surgery",
    "therapy_details": "High miR-21 was associated with poor therapeutic outcome",
    "expression": "Upregulated",
    "significance": "p=0.0008",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Mediate drug resistance to 5-FU",
    "expression": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "RKO cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-21 confers cisplatin resistance in Gc cells by regulating PTEN",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Correlated with tumor grade after preoperative chemoradiotherapy (P = 0.013) and with pathological response (P = 0.013)",
    "expression": "Upregulated",
    "significance": "Sensitivity=77.6%, Specificity=86.6%, NPV=6%, and PPV=92%",
    "detection_method": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Expression upregulated after CT",
    "expression": "Upregulated",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "36 tissues,FFPE",
    "continent": "Europe",
    "population": "Austria",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Treatment with antagonist sensitized 5FU resistant CRC",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "continent": "Europe",
    "population": "UK",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Silencing miR-21 when combined with chemotherapeutics (5-FU, L-OHP, and SN38), contributed to the decrease of cell viability.",
    "expression": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-483 & miR-214 expression predict less chemotherapy effect",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients with high expressions of miR-215 could benefit from 5-fluorouracil-containing adjuvant chemotherapy",
    "expression": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "Sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "continent": "South America",
    "population": "Brazil",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Increases ESCC cells chemosensitivity to cisplatin and suppresses tumor growth",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Enhanced 5-FU cytotoxicity by targeting enzyme thymidylate synthase",
    "expression": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tissues, 63 CRC patients",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-218 increased Gc cell chemosensitivity to cisplatin in vitro and inhibited gastric cell tumor growth in vivo (p<0.05)",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray,qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "Eca9706,Eca9706-CisR",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "High miR-22 expression sensitizes ESCC cells to irradiation",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-PCr",
    "sample_type": "Tissues",
    "sample": "100 ESCC, 100 normal epithelium",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulation of miR-223 significantly increases the sensitivity of 7901/DDP cells to DDp(cisplatin)",
    "expression": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "expression": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-223 reduced sensitivityto trastuzumab drug",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-23b-3p dramatically enhanced the sensitivity of SGC7902/VCR to 5-FU,VCR,CDDP",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Sensitizer in chemotherapy(cisplatin) for GC",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "sample_type": "Cell-line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-27a inhibitors alone or in combination with Perifosine suppresses growth of GC cells(AGS,MGC803)",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "67 GC & matched adjacent non tumor tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Chemotherapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR,northern blot",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20485139"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Loss of miR-296 may be one of the mechanisms for primary resistance of colorectal cancer to chemotherapy, poor response to treatment with Sunitinib and Capecitabine",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "continent": "USA",
    "population": "USA",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Bufalin inhibited cell proliferation and promoted cell apoptosis by down regulating miR-298",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "20 GC & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "mIR-29c was significantly activated by celecoxib in GC cells",
    "expression": "Downregulated",
    "significance": "p<0.005( early GC vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "53 GC &  matched non tumor tissues",
    "continent": "Asia",
    "population": "Tokyo and Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Low expression decreases chemosensitivity",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "20 drug treated GC tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-30a overexpression had higher DDP sensitivity than knockdown",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue",
    "sample": "20 platinum received tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Treatment with antagonist sensitized 5FU resistant CRC",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Predicted poor pathological response to neoadjuvant CRT",
    "expression": "Upregulated",
    "significance": "AUC=0.71, p=0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "FFPE biopsies from 78 patients",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Low expression had poor response to neoadjuvant CRT",
    "expression": "Downregulated",
    "significance": "P < 0.01",
    "detection_method": "TaqMan Low Density arrays",
    "sample_type": "Tissue and Cell line",
    "sample": "Tissue and Cell line OE33 P and OE33 R cells",
    "continent": "Europe",
    "population": "Ireland",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers of cetuximab response in wt-RAS mCRC patients",
    "expression": "N/A",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Marker for Response to EGFR therapy",
    "expression": "N/A",
    "significance": "For Training set 1: p=0.01, for training set 2: p=0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "sample_type": "Tissue",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "continent": "Europe",
    "population": "Paris",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers of cetuximab response in wt-RAS mCRC patients",
    "expression": "N/A",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-328 overexpression reversed drug resistance",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "miR-338-5p is downregulated in radioresiatant ESCC cells",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray,qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "TE-4,TE-4R",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-345 expression was associated with lack of response to treatment with cetuximab and irinotecan.",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "continent": "Europe",
    "population": "Denmark",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-34a overexpression improve sensitivity of GC cell against cisplatin based CT",
    "expression": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-34c-5p increased the chemosensitivity of Paclitaxel resistant GC cells",
    "expression": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "sample_type": "Sample Cell-line",
    "sample": "Paclitaxel resistant GC samples",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Expression down after chemotherapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue Serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy.",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Elevated expression of miR-21 reduced the sensitivity of RT",
    "expression": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "sample_type": "Tissue Serum",
    "sample": "Serum ,tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "miR-375 desensitizes cells to ionizing radiation and etoposide",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Downregulation of miR-377 expression was correlated with poor chemoresponse(5FU and cisplatin), high serum level inversely associated with chemoradiotherapy resistance",
    "expression": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulation of miR-377 expression was correlated with poor chemoresponse(5FU and cisplatin), high serum level inversely associated with chemoradiotherapy resistance",
    "expression": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Negative correlation between miR-381 expression and radioresistant capacity",
    "expression": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Prognostic indicator for chemo-response to 5-FU therapy",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-4299",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Discriminating chemoresistant colon cancer",
    "expression": "Downregulated",
    "significance": "AUC=0.810",
    "detection_method": "with laser capture microdissection and qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression decreases sensitivity of ESCC to chemotherapy drug cisplatin",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Tissue",
    "sample": "84 ESCC tumors",
    "continent": "Asia",
    "population": "Tokyo",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Antagonizing miR-455-3p  inhibits chemoresistance and aggressiveness in ESCC",
    "expression": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "ESCC specimen",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Improved outcome in the CAPEOXBEV cohorts and showed a significant interaction with bevacizumab effectiveness",
    "expression": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "continent": "Europe",
    "population": "Denmark",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-483 & miR-214 expression predict less chemotherapy effect",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-483-3p  inhibit cells sensitivity to chemotherapy drugs",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "sample_type": "Cell-line",
    "sample": "Cell lines",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in non-responders",
    "expression": "Upregulated",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "continent": "Europe",
    "population": "Norway",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "miR-573 correlated with preoperative chemoradiotherapy",
    "expression": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "continent": "Europe",
    "population": "Germany",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Increased in bevacizumab-induced cardiotoxicity",
    "expression": "N/A",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer",
    "expression": "Upregulated",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue Cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "continent": "Europe",
    "population": "Denmark",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Improved outcome in the CAPEOXBEV cohorts and showed a significant interaction with bevacizumab effectiveness",
    "expression": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "continent": "Europe",
    "population": "Denmark",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers for a poor response to vaccine treatment",
    "expression": "Upregulated",
    "significance": "Overall survival (p=0.003, hazard ratio, 3.67)",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers for a poor response to vaccine treatment",
    "expression": "Upregulated",
    "significance": "Overall survival (p=0.003, hazard ratio, 3.67)",
    "detection_method": "qRT-PCR",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "continent": "Asia",
    "population": "Japan",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "ESCC patients with higher miR-7 level were much more sensitive to CRT",
    "expression": "Downregulated",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "N/A",
    "sample_type": "Plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Promising predictive value of miR-939 expression regarding GC chemotherapy response (AUC =0.777, P < 0.001)",
    "expression": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,qRT-PCR",
    "sample_type": "Cell-line Tissue",
    "sample": "Cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC Patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Induces chemo or radio resistance by downregulating RECK in EC",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Induces chemo or radio resistance by downregulating RECK in EC",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Induces chemo or radio resistance by downregulating RECK in EC",
    "expression": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "therapy": "Radiotherapy",
    "therapy_details": "Upregulation of miR-98 increases radiosensitivity of ESCC cells, radiosensitivity in descending order: EC9706,KYSE30,KYSE450,TE1,ECA109,KYSE150",
    "expression": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Cell-line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "continent": "Cell-line",
    "population": "Cell-line",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "expression": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "continent": "Europe",
    "population": "Czech Republic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predicts chemotherapy response",
    "expression": "Upregulated",
    "significance": "p=0.027",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "continent": "Europe",
    "population": "Spain",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "Panel (Let-7c miR-99a miR-125b)",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "expression": "Panel",
    "significance": "N/A",
    "detection_method": "miRNA arrays",
    "sample_type": "Tissue",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "continent": "Europe",
    "population": "Italy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Panel (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "To predict complete vs. incomplete response to neoadjuvant CRT",
    "expression": "Panel",
    "significance": "N/A",
    "detection_method": "Microarray",
    "sample_type": "Tissue",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "continent": "Europe",
    "population": "Ireland",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Panel (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictor to response to  chemotherapy",
    "expression": "Panel",
    "significance": "AUC= 0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by qRT-PCR",
    "sample_type": "Serum",
    "sample": "Serum of 253 patients who had chemotherapy treatment",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "High-risk group were found to have a favourable response to adjuvant chemotherapy",
    "expression": "Panel",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "sample_type": "Tissue",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "continent": "Asia",
    "population": "China",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "Panel (miR-4299 and miR-196b)",
    "cancer": "Colon Cancer",
    "therapy": "Chemotherapy",
    "therapy_details": "Discriminating chemoresistant colon cancer",
    "expression": "Panel",
    "significance": "AUC=0.877",
    "detection_method": "with laser capture microdissection and qRT- PCR",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "continent": "Asia",
    "population": "China",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "Panel (miR-519c-3p and miR-561)",
    "cancer": "Rectal Cancer",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "To predict good vs. poor response to neoadjuvant CRT",
    "expression": "Panel",
    "significance": "N/A",
    "detection_method": "Microarray",
    "sample_type": "Tissue",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "continent": "Europe",
    "population": "Ireland",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  }
]